The strategy of targeting mitochondrial RNA polymerase should theoretically also be more broadly appropriate for other cancer types dependent on oxidative phosphorylation, such as certain types of breast cancer [25, 26], and subset of melanomas and pancreatic cancers [27, 28]. This evidence concerns the gene POLRMT and melanoma.